05/15/2024
6:39 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
6:14 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
6:34 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
4:15 PM | Adaptimmune Therapeutics (Filer)
| Form ARS | |
04/12/2024
7:05 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:00 AM | Adaptimmune Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
7:38 PM | Adaptimmune Therapeutics (Subject)
New Enterprise Associates 14, L.P. (Filed by)
| Form SC 13D/A | |
Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad) Right now, there’s over $6 trillion in potential investment money waiting on the sidelines.
That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… |
04/01/2024
7:01 AM | Adaptimmune Therapeutics (Filer)
| Form PRE 14A | |
03/26/2024
10:59 AM | Adaptimmune Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
03/26/2024
11:00 AM | Adaptimmune Therapeutics (Issuer)
EcoR1 Capital, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/06/2024
6:05 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:12 AM | Adaptimmune Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
7:13 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
4:07 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:26 PM | Adaptimmune Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
01/29/2024
10:52 AM | Adaptimmune Therapeutics (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
01/17/2024
4:30 PM | Adaptimmune Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:30 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:30 PM | Adaptimmune Therapeutics (Issuer)
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:31 PM | Adaptimmune Therapeutics (Issuer)
Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:31 PM | Adaptimmune Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:31 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:01 PM | Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:01 PM | Adaptimmune Therapeutics (Issuer)
Wood Gavin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:01 PM | Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:02 PM | Adaptimmune Therapeutics (Issuer)
Brewer Joanna Elizabeth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:02 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:03 PM | Adaptimmune Therapeutics (Issuer)
Hege Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:03 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:06 PM | Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:46 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
6:13 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
11:59 AM | Adaptimmune Therapeutics (Subject)
Long Focus Capital Management, LLC (Filed by)
| Form SC 13G | |
11/08/2023
6:37 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
7:07 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
6:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2023
4:19 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
6:42 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
4:01 PM | Adaptimmune Therapeutics (Issuer)
Menzel Garry E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
3:15 PM | Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
| Form SC 13G/A | |
Did You Get Your Free Bitcoin Yet? (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
07/03/2023
4:16 PM | Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:00 PM | Adaptimmune Therapeutics (Issuer)
Allen Andrew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:01 PM | Adaptimmune Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:02 PM | Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:02 PM | Adaptimmune Therapeutics (Issuer)
Sigal Charles Elliott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:03 PM | Adaptimmune Therapeutics (Issuer)
Menzel Garry E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:04 PM | Adaptimmune Therapeutics (Issuer)
Furey John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:04 PM | Adaptimmune Therapeutics (Issuer)
Hegde Priti (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:48 PM | Adaptimmune Therapeutics (Filer)
| Form S-8 POS | |
06/29/2023
3:54 PM | Adaptimmune Therapeutics (Filer)
| Form S-8 POS | |
06/29/2023
3:25 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
8:15 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
3:09 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2023
3:18 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2023
3:21 PM | Adaptimmune Therapeutics (Filed by)
TCR2 THERAPEUTICS INC. (Subject)
| Form 425 | |
